Rua Bioscience CEO Paul Naske today announced the expansion of the Rua Compassionate Access Programme.
The programme has been in place for 2 years, offering fully subsidised medicinal cannabis products to Tairawhiti patients unable to afford.
“This year Rua has increased its support from 30 to 37 patients a month, thanks to co-funding from Trust Tairāwhiti and other organisations,” said Mr Naske.
“Rua is deeply committed to making a positive impact on the community. Our kaupapa, since the day we were founded here in Ruatorea, has been to help improve the health and well-being of the people of Te Tairawhiti through innovative healthcare solutions.
“The Compassionate Access Programme is a key part of this mission, ensuring that those in need have access to vital medications.”
Mr Naske also announced that Rua is developing the programme’s scope, scale and reach to include local palliative care patients.
“Rua is working on further additions to the programme to cater specifically to palliative care patients in Ruatorea and the surrounding areas on the East Coast.
“This new initiative aims to provide fully subsidised, specialised support and care to people in their final stages of life.”
To find more information about the programme, go to:
https://www.ruabio.com/compassionate-access-programme
ENDS
The person who authorised this announcement:
Paul Naske
Chief Executive Officer
[email protected]
+64 21 445154
For media inquiries, please contact:
Darylene Rogers
Chief Impact Officer
[email protected]
+64 21 821353
Officials' idea for a giant lake would have cost billions and had serious impacts.
A transformational year is predicted for Aroa with maiden profit predicted.
The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details